Ductal carcinoma in situ (DCIS
and comedo pattern ( Figure) . He visited our hospital.
There was an excisional scar and no definite lump at his left mammary areola, and there were no palpable axillary or supraclavicular lymph nodes. An ultrasonography and a mammography showed no definite nodules and no calcifications. The patient underwent mastectomy with dissection of axillary lymph nodes. Histological examination showed no evidence of residual carcinoma in the excised specimen and no lymph node metastases. He is healthy, without adjuvant treatment, as of 13 months postoperatively.
DISCUSSION
Although Ductal carcinoma in situ (DCIS) of the breast has become a relatively common disease in women, however it remains a rare disease in men. 129 cases of male DCIS have been reported in the world until 1997, they were accounting for approximately 5 % of all male breast carcinomas3). In Japan, only 14 cases of male DCIS have been reported until 19984).
In the 1970s, the incidence of noninvasive carcinoma was about 2 % of all carcinoma of the breast in Uchida, Tsuzuki, Ando, Yoshikawa, Sekihara, Kobayashi, Ide, Ohno, Kuwano women5). Two types of noninvasive carcinoma were described : lobular carcinoma in situ and DCIS. The widespread use of screening mammography has resulted in a vast increase in the discovery of DCIS1,6). This increase in noninvasive disease has almost exclusively been in asymptomatic DCIS, whereas the ratio of lobular carcinoma in situ and the rate of symptomatic DCIS (mass, nipple discharge, Paget's disease) has remained relatively stable.
Breast carcinoma
is not common in men. Male breast carcinoma has a tendency to be presented at higher clinical stages, displays more frequent lymph node metastases8,9). However, for comparable stages of this disease, significant prognostic differences do not exist between male and female breast carcinoma9,10). Despite the information accumulated to date regarding invasive carcinoma of the male breast, very little is known regarding the precusor lesion DCIS.
Clinically, male DCIS most often presents two most characteristic symptoms, one is a slowly growing subareolar mass and the other is serosanguineous nipple discharge4,11). Other symptoms such as bilateral gynecomastia and mastitis were rare11). Because of its rarity, this disease is associated with a lack of some examinations and a risk of error in diagnosis.
In our case, the tumor was removed before the patients was seen at our hospital. Therefore we could not have any important infomations, such as the findings of mammography or ultrasonography.
As to the histological subtypes of male DCIS, there is predominance of the papillary forms : pure, intracystic or with an associated cribriform component.
In occurs after lumpectomy alone12). In conclusion, total mastectomy without axillary dissection is the standard approach to DCIS in the male patient. No adjuvant treatment is required3). However we have to consider axillary dissection if the lesion is suspected to be positive at the surgical margin after excisional biopsy. Because the risk of microinvasion would be undeniable.
